UREX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Urex, and what generic alternatives are available?
Urex is a drug marketed by Alvogen and is included in one NDA.
The generic ingredient in UREX is methenamine hippurate. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Urex
A generic version of UREX was approved as methenamine hippurate by AUROBINDO PHARMA LTD on July 5th, 2016.
Summary for UREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 138 |
| Patent Applications: | 4,049 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | UREX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for UREX
US Patents and Regulatory Information for UREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | UREX | methenamine hippurate | TABLET;ORAL | 016151-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
